You are here: Home » News-CM » Companies » Results
Business Standard

Dishman Pharmaceuticals and Chemicals consolidated net profit declines 14.28% in the March 2017 quarter

Capital Market 

Sales rise 20.07% to Rs 487.10 crore

Net profit of Dishman Pharmaceuticals and Chemicals declined 14.28% to Rs 42.79 crore in the quarter ended March 2017 as against Rs 49.92 crore during the previous quarter ended March 2016. Sales rose 20.07% to Rs 487.10 crore in the quarter ended March 2017 as against Rs 405.67 crore during the previous quarter ended March 2016.

For the full year,net profit declined 15.01% to Rs 145.43 crore in the year ended March 2017 as against Rs 171.12 crore during the previous year ended March 2016. Sales rose 4.61% to Rs 1633.86 crore in the year ended March 2017 as against Rs 1561.85 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales487.10405.67 20 1633.861561.85 5 OPM %30.0125.78 -27.6926.27 - PBDT139.8697.06 44 429.58342.42 25 PBT82.8767.16 23 216.08233.36 -7 NP42.7949.92 -14 145.43171.12 -15

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, May 17 2017. 16:28 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU